Literature DB >> 15891198

Detection of cerebral {beta}-hydroxy butyrate, acetoacetate, and lactate on proton MR spectroscopy in children with diabetic ketoacidosis.

Sandra L Wootton-Gorges1, Michael H Buonocore, Nathan Kuppermann, James Marcin, Joseph Dicarlo, E Kirk Neely, Patrick D Barnes, Nicole Glaser.   

Abstract

BACKGROUND AND
PURPOSE: Ketone bodies provide important alternate fuel for brain metabolism, and their transport into the brain increases with prolonged fasting. During diabetic ketoacidosis (DKA), serum ketone concentrations markedly increase; however, little is known about whether ketone bodies accumulate in cerebral tissues during DKA. We used proton MR spectroscopy (MRS) to detect cerebral beta-hydroxy butyrate (betaOHB) and acetone/acetocaetate (AcAc) in children with DKA.
METHODS: Twenty-five children underwent brain MRS: nine within 4 hours of the start of treatment for DKA; 11, at 4-8 hours; and five, at 8-12 hours. MRS was repeated after their recovery from the DKA episode at > or =72 hours after the start of treatment. MRS was evaluated for peaks corresponding to betaOHB (doublet centered on 1.20 ppm) and lactate (doublet centered on 1.33 ppm). Difference spectroscopy was used to identify the AcAc peak at 2.22-2.26 ppm.
RESULTS: betaOHB was detected in 13 children (52%), more frequently within 4 hours (eight children, 89%) than after 4 hours (five children, 31%). AcAc was detected in 15 children (60%), more frequently at >4 hours after the start of treatment (12 patients, 75%) than in the first 4 hours (three patients, 33%). Lactate was detected in five children (18%), all within the first 8 hours of treatment.
CONCLUSION: In children, betaOHB and AcAc accumulate in the brain during DKA, and they can be detected on MRS. Care should be taken in interpreting MRS results in patients with DKA to avoid erroneously attributing betaOHB peaks to lactate.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15891198      PMCID: PMC8158622     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  23 in total

1.  Proton MR spectroscopy in children with acute brain injury: comparison of short and long echo time acquisitions.

Authors:  B A Holshouser; S Ashwal; S Shu; D B Hinshaw
Journal:  J Magn Reson Imaging       Date:  2000-01       Impact factor: 4.813

2.  Brain infarction in children with diabetic ketoacidosis.

Authors:  T F Roe; T O Crawford; K R Huff; G Costin; F R Kaufman; M D Nelson
Journal:  J Diabetes Complications       Date:  1996 Mar-Apr       Impact factor: 2.852

3.  Identification of cerebral acetone by 1H-MRS in patients with epilepsy controlled by ketogenic diet.

Authors:  K J Seymour; S Bluml; J Sutherling; W Sutherling; B D Ross
Journal:  MAGMA       Date:  1999-03       Impact factor: 2.310

4.  Acetoacetate and beta-hydroxybutyrate differentially regulate endothelin-1 and vascular endothelial growth factor in mouse brain microvascular endothelial cells.

Authors:  C M Isales; L Min; W H Hoffman
Journal:  J Diabetes Complications       Date:  1999 Mar-Apr       Impact factor: 2.852

Review 5.  Role of oxidative stress in development of complications in diabetes.

Authors:  J W Baynes
Journal:  Diabetes       Date:  1991-04       Impact factor: 9.461

6.  Brain metabolism during fasting.

Authors:  O E Owen; A P Morgan; H G Kemp; J M Sullivan; M G Herrera; G F Cahill
Journal:  J Clin Invest       Date:  1967-10       Impact factor: 14.808

7.  Alterations in free radical scavenger system profile of type I diabetic rat brain.

Authors:  S K Bhardwaj; P Sharma; G Kaur
Journal:  Mol Chem Neuropathol       Date:  1998 Aug-Dec

8.  Effect of endogenous beta-hydroxybutyrate on brain glucose metabolism in fetuses of diabetic rabbits, studied by (13)C magnetic resonance spectroscopy.

Authors:  Aviva Lapidot; Shelley Haber
Journal:  Brain Res Dev Brain Res       Date:  2002-04-30

9.  Effect of endogenous beta-hydroxybutyrate on glucose metabolism in the diabetic rabbit brain: a (13)C-magnetic resonance spectroscopy study of [U-(13)C]glucose metabolites.

Authors:  A Lapidot; S Haber
Journal:  J Neurosci Res       Date:  2001-04-15       Impact factor: 4.164

10.  Oral beta-hydroxybutyrate supplementation in two patients with hyperinsulinemic hypoglycemia: monitoring of beta-hydroxybutyrate levels in blood and cerebrospinal fluid, and in the brain by in vivo magnetic resonance spectroscopy.

Authors:  Barbara Plecko; Sylvia Stoeckler-Ipsiroglu; Edith Schober; Georg Harrer; Vladimir Mlynarik; Stephan Gruber; Ewald Moser; Dorothea Moeslinger; Heinz Silgoner; Osman Ipsiroglu
Journal:  Pediatr Res       Date:  2002-08       Impact factor: 3.756

View more
  19 in total

Review 1.  Central nervous system involvement in diabetes mellitus.

Authors:  Dinesh Selvarajah; Solomon Tesfaye
Journal:  Curr Diab Rep       Date:  2006-12       Impact factor: 4.810

Review 2.  Hyperglycemic comas in children: new insights into pathophysiology and management.

Authors:  Arlan L Rosenbloom
Journal:  Rev Endocr Metab Disord       Date:  2005-12       Impact factor: 6.514

3.  Cerebral hyperemia measured with near infrared spectroscopy during treatment of diabetic ketoacidosis in children.

Authors:  Nicole S Glaser; Daniel J Tancredi; James P Marcin; Ryan Caltagirone; Yvonne Lee; Christopher Murphy; Nathan Kuppermann
Journal:  J Pediatr       Date:  2013-07-18       Impact factor: 4.406

4.  Human amylin proteotoxicity impairs protein biosynthesis, and alters major cellular signaling pathways in the heart, brain and liver of humanized diabetic rat model in vivo.

Authors:  Amro Ilaiwy; Miao Liu; Traci L Parry; James R Bain; Christopher B Newgard; Jonathan C Schisler; Michael J Muehlbauer; Florin Despa; Monte S Willis
Journal:  Metabolomics       Date:  2016-04-23       Impact factor: 4.290

5.  Changes in cerebral metabolism during ketogenic diet in patients with primary brain tumors: 1H-MRS study.

Authors:  Moran Artzi; Gilad Liberman; Nachum Vaisman; Felix Bokstein; Faina Vitinshtein; Orna Aizenstein; Dafna Ben Bashat
Journal:  J Neurooncol       Date:  2017-01-10       Impact factor: 4.130

6.  Postmortem 1H-MRS-Detection of Ketone Bodies and Glucose in Diabetic Ketoacidosis.

Authors:  Jakob Heimer; Dominic Gascho; Vasiliki Chatzaraki; Damaris Fröhlich Knaute; Vera Sterzik; Rosa Maria Martinez; Michael J Thali; Niklaus Zoelch
Journal:  Int J Legal Med       Date:  2017-11-23       Impact factor: 2.686

Review 7.  β-Hydroxybutyrate in the Brain: One Molecule, Multiple Mechanisms.

Authors:  Lavanya B Achanta; Caroline D Rae
Journal:  Neurochem Res       Date:  2016-11-08       Impact factor: 3.996

8.  Presenting predictors and temporal trends of treatment-related outcomes in diabetic ketoacidosis.

Authors:  Christopher M Horvat; Heba M Ismail; Alicia K Au; Luigi Garibaldi; Nalyn Siripong; Sajel Kantawala; Rajesh K Aneja; Diane S Hupp; Patrick M Kochanek; Robert Sb Clark
Journal:  Pediatr Diabetes       Date:  2018-04-26       Impact factor: 4.866

9.  Cerebral metabolic alterations in rats with diabetic ketoacidosis: effects of treatment with insulin and intravenous fluids and effects of bumetanide.

Authors:  Nicole Glaser; Natalie Yuen; Steven E Anderson; Daniel J Tancredi; Martha E O'Donnell
Journal:  Diabetes       Date:  2009-12-22       Impact factor: 9.461

10.  Cerebral proton magnetic resonance spectroscopy in children with diabetic ketoacidosis.

Authors:  S L Wootton-Gorges; M H Buonocore; N Kuppermann; J P Marcin; P D Barnes; E K Neely; J DiCarlo; T McCarthy; N S Glaser
Journal:  AJNR Am J Neuroradiol       Date:  2007-05       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.